Whole blood collected on filter paper (Guthrie cards) has provided an
excellent means for screening inborn errors of metabolism in neonates.
Traditional biochemical methods adapted for use with this collection
device have proven instrumental in the detection of many congenital de
fects such as phenylketonuria, galactosemia, hypothyroidism and hemogl
obinopathies. The advent of molecular techniques, specifically polymer
ase chain reaction (PCR), has resulted in unparalleled advances in dia
gnostic sensitivity. Because of its ability to amplify small quantitie
s of deoxyribonucleic acid (DNA), PCR has proven particularly successf
ul for use with Guthrie card bloodspots in the identification of many
genetic disorders including cystic fibrosis, sickle cell anemia and mu
scular dystrophy. Furthermore, it has been suggested that Guthrie card
s represent a vast archive of genomic material yet to be explored. In
this article we review our experience using Guthrie card bloodspots fo
r PCR amplification of the cystic fibrosis gene, describe the advantag
es and limitations of this technology and speculate on future prospect
s for molecular diagnostics over the next 100 years.